Great Britain
The article describes in detail the approach the UK authority intends to apply when implementing amendments to the existing legal framework.
Great Britain
The new article provides additional clarifications regarding the upcoming changes to the UK regulatory framework.
MHRA
The article provides an overview of the current reporting requirements for healthcare products allowed to be used for clinical trials.
AIaMD
The article provides a general overview of the new regulatory framework for innovative AI-based healthcare products intended to be marketed and used in the UK.
Canada
The article describes the approach to be applied to innovative medical devices utilizing machine-learning technology.
Great Britain
The new article outlines the list of questions raised by the regulating authority in the context of the initiated consultation and also provides definitions of the most important terms and concepts used.
